These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1975571)

  • 1. Forskolin and prostaglandin E2 regulate the generation of human cytolytic T lymphocytes.
    Khan MM; Tran AC; Keaney KM
    Immunopharmacology; 1990; 19(3):151-61. PubMed ID: 1975571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activated T cells display increased sensitivity to PGE2.
    Sunder-Plassmann R; Majdic O; Knapp W; Holter W
    Cell Immunol; 1991 Dec; 138(2):289-99. PubMed ID: 1657408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrocortisone suppresses the generation of nonspecific "anomalous" killers but not specific cytolytic T lymphocytes in human mixed lymphocyte-tumor cultures.
    Muul LM; Gately MK
    J Immunol; 1984 Mar; 132(3):1202-7. PubMed ID: 6198383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of murine adherent interleukin-2-activated killer cells. Differential effect of prostaglandin E2 and forskolin.
    Vaillier D; Daculsi R; Gualde N
    Cancer Immunol Immunother; 1995 Jan; 40(1):65-71. PubMed ID: 7828169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
    Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
    J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity to cAMP among human cord and maternal/adult peripheral lymphocytes discloses differences between PHA- and OKT3-induced activation pathways.
    Papadogiannakis N; Johnsen SA; Rosberg S; Andersson RG; Olding LB
    Immunology; 1989 Nov; 68(3):378-83. PubMed ID: 2556345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1.
    Alava MA; DeBell KE; Conti A; Hoffman T; Bonvini E
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):189-99. PubMed ID: 1318020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of murine cytotoxic T-lymphocyte induction following exposure to 7,12-dimethylbenz[A]anthracene: dysfunction of antigen recognition.
    House RV; Pallardy MJ; Dean JH
    Int J Immunopharmacol; 1989; 11(2):207-15. PubMed ID: 2495255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
    Jennings SR; Bonneau RH; Smith PM; Wolcott RM; Chervenak R
    Cell Immunol; 1991 Mar; 133(1):234-52. PubMed ID: 1671342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandin E2 and other intracellular cyclic AMP elevating agents on the mitogen induced mouse splenocyte proliferation in a serum free culture condition.
    Zhong WW; Chavali SR; Forse RA
    Life Sci; 1994; 55(11):PL193-8. PubMed ID: 8072381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
    Thiele DL; Lipsky PE
    J Immunol; 1986 Aug; 137(4):1399-406. PubMed ID: 3488348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell lysis by T cells distinct from NK cells and alloantigen-specific cytotoxic T cells.
    Thiele DL; Lipsky PE
    Clin Immunol Immunopathol; 1988 Dec; 49(3):405-23. PubMed ID: 2461269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
    Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G
    Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.
    Ottenhoff TH; Mutis T
    J Exp Med; 1990 Jun; 171(6):2011-24. PubMed ID: 1972178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
    Susskind BM; Chandrasekaran J
    J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting human peripheral blood lymphocytes can be activated to cytolytic function by antibodies to CD3 in the absence of exogenous interleukin-2.
    Scott CF; Lambert JM; Bolender S; Blattler WA
    Cell Immunol; 1988 Jul; 114(2):370-84. PubMed ID: 3260543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.
    Cassell D; Forman J
    J Immunol; 1991 Jan; 146(1):3-10. PubMed ID: 1670605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.